Literature DB >> 19679633

Pediatric brain natriuretic peptide concentrations vary with age and sex and appear to be modulated by testosterone.

Amy K Saenger1, Daniel A Dalenberg, Sandra C Bryant, Stefan K Grebe, Allan S Jaffe.   

Abstract

BACKGROUND: Natriuretic peptide concentrations in adults require age- and sex-specific reference intervals for optimal interpretation. Females have higher natriuretic peptide concentrations, and hypotheses suggest that estrogen may be responsible. This study sought to determine the influence of hormone modulation on N-terminal probrain natriuretic peptide (NT-proBNP) by using a pediatric cohort. Children/adolescents typically have rapid hormone changes during puberty, making them an ideal group to study.
METHODS: We selected 759 specimens (303 male, 456 female; ages 2 months to 18 years, mean 13 years) obtained from the Mayo Clinic Pediatric Residual Specimen Bank. We measured NT-proBNP, sex hormone-binding globulin (SHBG), estradiol, and testosterone by immunoassays or LC-MS/MS and calculated free testosterone. We performed univariate and multivariate analyses to investigate the significance of NT-proBNP with each hormone.
RESULTS: Reference values demonstrated a sex difference and sequential age differences in females. Univariate modeling of the hormones with NT-proBNP revealed an independent inverse association of NT-proBNP with testosterone, a direct association with SHBG, and no significant association with estradiol. Multivariate modeling confirmed a strong association of testosterone and SHBG with NT-proBNP. Correlation of hormones with NT-proBNP retained greater significance than either age or sex.
CONCLUSIONS: In pediatric patients, NT-proBNP is independently associated with both testosterone and SHBG hormone concentrations. Measurements of testosterone are inversely associated with NT-proBNP, and estrogens are marginally associated with NT-proBNP in males but not females, suggesting that androgens and not estrogens modulate sex differences notable in natriuretic peptides. Children and adolescents may require an objective assessment of hormones if optimal interpretation of natriuretic peptide concentrations is desired or the concentrations are confounded. .

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19679633     DOI: 10.1373/clinchem.2009.123778

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  11 in total

1.  Impact of the look AHEAD intervention on NT-pro brain natriuretic peptide in overweight and obese adults with diabetes.

Authors:  Alain G Bertoni; Lynne E Wagenknecht; Dalane W Kitzman; Santica M Marcovina; Julia T Rushing; Mark A Espeland
Journal:  Obesity (Silver Spring)       Date:  2011-09-29       Impact factor: 5.002

2.  Reference limits for N-terminal-pro-B-type natriuretic peptide in healthy individuals (from the Framingham Heart Study).

Authors:  Michael G Fradley; Martin G Larson; Susan Cheng; Elizabeth McCabe; Erin Coglianese; Ravi V Shah; Daniel Levy; Ramachandran S Vasan; Thomas J Wang
Journal:  Am J Cardiol       Date:  2011-08-23       Impact factor: 2.778

3.  Influence of sex and hormone status on circulating natriuretic peptides.

Authors:  Carolyn S P Lam; Susan Cheng; Karen Choong; Martin G Larson; Joanne M Murabito; Christopher Newton-Cheh; Shalender Bhasin; Elizabeth L McCabe; Karen K Miller; Margaret M Redfield; Ramachandran S Vasan; Andrea D Coviello; Thomas J Wang
Journal:  J Am Coll Cardiol       Date:  2011-08-02       Impact factor: 24.094

4.  Factors associated with serum brain natriuretic peptide levels after the Fontan procedure.

Authors:  Andrew M Atz; Victor Zak; Roger E Breitbart; Steven D Colan; Sara K Pasquali; Daphne T Hsu; Minmin Lu; Lynn Mahony; Stephen M Paridon; Michael D Puchalski; Tal Geva; Brian W McCrindle
Journal:  Congenit Heart Dis       Date:  2011-03-25       Impact factor: 2.007

5.  Distribution of High-Sensitivity Cardiac Troponin and N-Terminal Pro-Brain Natriuretic Peptide in Healthy Transgender People.

Authors:  Dina N Greene; Robert L Schmidt; Robert H Christenson; Jessica Rongitsch; Katherine L Imborek; Heather Rebuck; Thomas S Lorey; Amy K Saenger; Matthew D Krasowski
Journal:  JAMA Cardiol       Date:  2022-10-05       Impact factor: 30.154

6.  Serum corin is reduced and predicts adverse outcome in non-ST-elevation acute coronary syndrome.

Authors:  Aviva Peleg; Diab Ghanim; Shiraz Vered; Yonathan Hasin
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-06

7.  Impact of socioeconomic and cardiovascular risk factors on the effect of genetic variants associated with NT-proBNP.

Authors:  Emanuel Matusch; Mirjam Frank; Kaffer Kara; Amir A Mahabadi; Nico Dragano; Raimund Erbel; Karl-Heinz Jöckel; Börge Schmidt
Journal:  Sci Rep       Date:  2022-09-16       Impact factor: 4.996

8.  Cardiovascular, anthropometric, metabolic and hormonal profiling of normotensive women with polycystic ovary syndrome with and without biochemical hyperandrogenism.

Authors:  Małgorzata Kałużna; Tomasz Krauze; Katarzyna Ziemnicka; Katarzyna Wachowiak-Ochmańska; Jolanta Kaczmarek; Adam Janicki; Andrzej Wykrętowicz; Marek Ruchała; Przemysław Guzik
Journal:  Endocrine       Date:  2021-02-22       Impact factor: 3.633

Review 9.  Sex-related differences in contemporary biomarkers for heart failure: a review.

Authors:  Navin Suthahar; Laura M G Meems; Jennifer E Ho; Rudolf A de Boer
Journal:  Eur J Heart Fail       Date:  2020-03-27       Impact factor: 15.534

10.  Age-Dependent Reference Values for hs-Troponin T and NT-proBNP and Determining Factors in a Cohort of Healthy Children (The LIFE Child Study).

Authors:  Alexandra Kiess; Jessica Green; Anja Willenberg; Uta Ceglarek; Ingo Dähnert; Anne Jurkutat; Antje Körner; Andreas Hiemisch; Wieland Kiess; Mandy Vogel
Journal:  Pediatr Cardiol       Date:  2022-03-12       Impact factor: 1.838

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.